Sclerotherapy and Candida Antigen in Treatment of Common Warts

ConditionCommon Wart

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-60

SponsorSohag University

About this trial

This study aims to evaluate the efficacy and safety of intralesional injections of candida antigen, polidocanol sclerotherapy and combined candida antigen with polidocanol in treatment of patients with common warts.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age group: >18years.

Confirmed diagnosis by clinical and dermoscopic examination of common wart will be made.

Disqualifiers

Patients who receive any treatment for wart in the last month before the study.

Patients with history of renal or liver disease.

Patients with any evidence of bleeding diathesis, vaso-occulusive or thrombo-embolic disorders.

Pregnant and lactating females.

Trial design

Design model

Parallel

Treatments tested in this trial

polidacanol 3%
Drug
Aethoxysklerol 3%,60mg/ ml ampoule, kreussler pharma, Germany
candida antigen
Biological/Vaccine
delayed type of hypersensitivity reaction is induced toward the injected antigen and the wart virus as well. This can increase the ability of the immune system to recognize and eradicate the human papillomavirus on various parts of the body and eliminate the necessity of local treatment for each wart

Treatment groups

75 Participants

are divided into 3 treatment groups

Group A: PolidacanolActive comparator 1 intervention

Group B: CandidaActive comparator 1 intervention

Group C: Polidacanol and candidaActive comparator 2 interventions

Trial outcomes

Primary outcomes

size of warts

measured by ruler) with photographic comparison at base line and before each session and one month after last session in relation to baseline lesion to detect response to therapy

Time frame

session every 2 weeks until complete clearance of warts or for a maximum of 6 treatment sessions and one month after last session

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: